US Stock MarketDetailed Quotes

Fulcrum Therapeutics (FULC)

Watchlist
  • 10.750
  • -0.300-2.71%
Close Jan 23 16:00 ET
  • 10.750
  • 0.0000.00%
Post 17:14 ET
709.18MMarket Cap-9.43P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fulcrum Therapeutics (FULC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
2,752.05%80M
0
0
8,990.91%80M
0
-55.77%2.81M
27.15%871K
Operating revenue
--0
--0
--0
2,752.05%80M
--0
--0
8,990.91%80M
--0
-55.77%2.81M
27.15%871K
Cost of revenue
Gross profit
Operating expense
-5.22%21.86M
-27.97%19.82M
-31.61%20.4M
-12.02%99.83M
-32.69%19.43M
-18.21%23.06M
-2.36%27.51M
5.66%29.83M
-4.23%113.47M
0.58%28.86M
Selling and administrative expenses
-10.23%7.56M
-33.37%6.83M
-30.43%7M
-12.53%36.45M
-21.78%7.72M
-15.43%8.42M
-0.74%10.25M
-12.66%10.06M
-0.06%41.67M
-2.63%9.86M
-General and administrative expense
-10.23%7.56M
-33.37%6.83M
-30.43%7M
-12.53%36.45M
-21.78%7.72M
-15.43%8.42M
-0.74%10.25M
-12.66%10.06M
-0.06%41.67M
-2.63%9.86M
Research and development costs
-2.34%14.3M
-24.76%12.99M
-32.21%13.4M
-11.72%63.39M
-38.35%11.71M
-19.73%14.64M
-3.29%17.26M
18.29%19.77M
-6.49%71.8M
2.33%19M
Operating profit
5.22%-21.86M
-137.75%-19.82M
31.61%-20.4M
82.08%-19.83M
30.59%-19.43M
15.95%-23.06M
292.33%52.49M
-6.78%-29.83M
1.31%-110.66M
0.07%-27.99M
Net non-operating interest income expense
Other net income (expense)
65.54%2.26M
-13.64%2.52M
-7.29%2.75M
-24.16%10.11M
-11.59%2.86M
-60.06%1.37M
-16.87%2.92M
-6.23%2.96M
489.00%13.33M
72.49%3.24M
Special income (charges)
--0
----
----
---2.06M
--0
---2.06M
----
----
--0
--0
-Less：Restructuring and merger&acquisition
--0
----
----
--2.06M
--0
--2.06M
----
----
--0
--0
Other non- operating income (expenses)
-34.02%2.26M
-13.64%2.52M
-7.29%2.75M
-8.68%12.17M
-11.59%2.86M
0.20%3.43M
-16.87%2.92M
-6.23%2.96M
395.50%13.33M
76.06%3.24M
Income before tax
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
Income tax
Net income
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
Net income continuous Operations
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
Minority interest income
Net income attributable to the parent company
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
9.68%-19.6M
-131.22%-17.3M
34.29%-17.66M
90.01%-9.73M
33.07%-16.57M
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
Basic earnings per share
11.43%-0.31
-131.46%-0.28
34.88%-0.28
89.94%-0.16
22.50%-0.31
10.26%-0.35
334.21%0.89
-4.88%-0.43
34.84%-1.59
20.00%-0.4
Diluted earnings per share
11.43%-0.31
-132.18%-0.28
34.88%-0.28
89.94%-0.16
22.50%-0.31
10.26%-0.35
328.95%0.87
-4.88%-0.43
34.84%-1.59
20.00%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0002,752.05%80M008,990.91%80M0-55.77%2.81M27.15%871K
Operating revenue --0--0--02,752.05%80M--0--08,990.91%80M--0-55.77%2.81M27.15%871K
Cost of revenue
Gross profit
Operating expense -5.22%21.86M-27.97%19.82M-31.61%20.4M-12.02%99.83M-32.69%19.43M-18.21%23.06M-2.36%27.51M5.66%29.83M-4.23%113.47M0.58%28.86M
Selling and administrative expenses -10.23%7.56M-33.37%6.83M-30.43%7M-12.53%36.45M-21.78%7.72M-15.43%8.42M-0.74%10.25M-12.66%10.06M-0.06%41.67M-2.63%9.86M
-General and administrative expense -10.23%7.56M-33.37%6.83M-30.43%7M-12.53%36.45M-21.78%7.72M-15.43%8.42M-0.74%10.25M-12.66%10.06M-0.06%41.67M-2.63%9.86M
Research and development costs -2.34%14.3M-24.76%12.99M-32.21%13.4M-11.72%63.39M-38.35%11.71M-19.73%14.64M-3.29%17.26M18.29%19.77M-6.49%71.8M2.33%19M
Operating profit 5.22%-21.86M-137.75%-19.82M31.61%-20.4M82.08%-19.83M30.59%-19.43M15.95%-23.06M292.33%52.49M-6.78%-29.83M1.31%-110.66M0.07%-27.99M
Net non-operating interest income expense
Other net income (expense) 65.54%2.26M-13.64%2.52M-7.29%2.75M-24.16%10.11M-11.59%2.86M-60.06%1.37M-16.87%2.92M-6.23%2.96M489.00%13.33M72.49%3.24M
Special income (charges) --0-----------2.06M--0---2.06M----------0--0
-Less：Restructuring and merger&acquisition --0----------2.06M--0--2.06M----------0--0
Other non- operating income (expenses) -34.02%2.26M-13.64%2.52M-7.29%2.75M-8.68%12.17M-11.59%2.86M0.20%3.43M-16.87%2.92M-6.23%2.96M395.50%13.33M76.06%3.24M
Income before tax 9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M
Income tax
Net income 9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M
Net income continuous Operations 9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M
Minority interest income
Net income attributable to the parent company 9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 9.68%-19.6M-131.22%-17.3M34.29%-17.66M90.01%-9.73M33.07%-16.57M9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M
Basic earnings per share 11.43%-0.31-131.46%-0.2834.88%-0.2889.94%-0.1622.50%-0.3110.26%-0.35334.21%0.89-4.88%-0.4334.84%-1.5920.00%-0.4
Diluted earnings per share 11.43%-0.31-132.18%-0.2834.88%-0.2889.94%-0.1622.50%-0.3110.26%-0.35328.95%0.87-4.88%-0.4334.84%-1.5920.00%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.28%
Sample Name
Sample Code
 +3.09%
Sample Name
Sample Code
 +2.74%
4
Amazon
AMZN
+2.06%
5
Clean Energy Fuels
CLNE
+1.75%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +20.18%
Sample Name
Sample Code
 +8.06%
Sample Name
Sample Code
 +4.49%
4
KE Holdings
BEKE
+3.82%
5
Pony AI
PONY
+3.59%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -